Ubs Group Ag Nkarta, Inc. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Nkarta, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 240,456 shares of NKTX stock, worth $401,561. This represents 0.0% of its overall portfolio holdings.
Number of Shares
240,456
Previous 281,668
14.63%
Holding current value
$401,561
Previous $701,000
36.95%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding NKTX
# of Institutions
118Shares Held
61MCall Options Held
13.7KPut Options Held
10.3K-
Ra Capital Management, L.P. Boston, MA10.8MShares$18 Million0.41% of portfolio
-
Tang Capital Management LLC San Diego, CA7.06MShares$11.8 Million0.84% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$6.78 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$6.29 Million3.2% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$5.96 Million0.62% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $81.3M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...